IP Library Granted Patent US 8,315,693
Granted Patent B2
US 8,315,693 · App. 11/679,154 · Granted Nov 20, 2012

Electrocardiogram monitoring

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,315,693
App. No.
11/679,154
Granted
Nov 20, 2012
Kind
B2
Abstract

Techniques for determining whether one or more leads are not adequately connected to a patient, e.g., for ECG monitoring, are described. The techniques involve injection of an integrated signal (which includes a test signal) into one lead, and monitoring the driven lead and the response at the other leads, including the common mode and the difference between the other leads. These “lead-off” detection techniques may be provided by an external defibrillator that provides three-wire ECG monitoring. Techniques for determining a type of a cable coupled to a defibrillator are also described. The cable-type identification may allow a defibrillator to, for example, operate in either a three-wire ECG monitoring mode or a therapy mode, based on whether a three-wire ECG cable or a defibrillation cable is coupled to the defibrillator.

Claims (40)

1. A method, comprising

receiving a common mode signal via a first lead and a second lead coupled to an electrocardiogram monitoring device;

integrating, using an integrator, a test signal and the common mode signal to generate an integrated signal;

injecting the integrated signal into a third lead coupled to the electrocardiogram monitoring device;

generating a difference signal based on a difference between a first signal obtained via the first lead and a second signal obtained via the second lead; and

indicating which one or more of the first lead, the second lead, and the third lead are not adequately connected to a patient based on the integrated signal and the difference signal.

2. The method of claim 1 , further comprising determining at least one of an amplitude or a DC offset of the integrated signal, wherein indicating whether any of the first lead, the second lead, and the third lead are not adequately connected to the patient comprises indicating whether any of the first lead, the second lead, and the third lead are not adequately connected to the patient based on the at least one of the amplitude or the DC offset.

3. The method of claim 2 , further comprising determining whether at least one of the amplitude or DC offset exceeds a respective threshold, wherein indicating whether any of the first lead, the second lead, and the third lead are not adequately connected to the patient comprises indicating that either the third lead, both the first lead and the second lead, or all leads are not adequately connected to the patient if the at least one of the amplitude or the DC offset exceeds the respective threshold.

4. The method of claim 1 , further comprising determining whether the difference signal exceeds a threshold, wherein indicating whether any of the first lead, the second lead, and the third lead are not adequately connected to the patient comprises indicating that either the first lead or the second lead is not adequately connected to the patient if the difference signal exceeds the threshold.

5. A method, comprising:

receiving a common mode signal via a first lead and a second lead coupled to an electrocardiogram monitoring device;

integrating, using an integrator, a test signal and the common mode signal to generate an integrated signal;

injecting the integrated signal into a third lead coupled to the electrocardiogram monitoring device;

generating a difference signal based on a difference between a first signal obtained via the first lead and a second signal obtained via the second lead;

indicating whether any of the first lead, the second lead, and the third lead are not adequately connected to a patient based on the integrated signal and the difference signal;

determining whether the difference signal exceeds a threshold, wherein indicating whether any of the first lead, the second lead, and the third lead are not adequately connected to the patient comprises indicating that either the first lead or the second lead is not adequately connected to the patient if the difference signal exceeds the threshold;

determining a phase of the difference signal relative to the test signal; and

indicating which of the first lead or the second lead is not adequately connected to the patient based on the phase.

6. The method of claim 5 , wherein injecting an integrated signal into a third lead and receiving a common mode signal via a first lead and a second lead comprise injecting the integrated signal into a left arm lead and receiving the common mode signal via a left leg lead and a right arm lead.

7. The method of claim 5 , wherein injecting the integrated signal into the third lead coupled to the electrocardiogram monitoring device and receiving the common mode signal via the first lead and the second lead coupled to the electrocardiogram monitoring device comprise injecting the integrated signal into the third lead coupled to an automated external defibrillator and receiving the common mode signal via the first lead and the second lead coupled to the automated external defibrillator.

8. An electrocardiogram monitoring device comprising:

an integrator that receives a common mode signal via a first lead and a second lead coupled to an electrocardiogram monitoring device, and integrates a test signal and the common mode signal to generate an integrated signal;

a drive circuit that injects the integrated signal into a third lead coupled to the electrocardiogram monitoring device;

a difference unit that generates a difference signal based on a difference between a first signal obtained via the first lead and a second signal obtained via the second lead; and

a processor that indicates whether any of the first lead, the second lead and the third lead are not adequately connected to the patient based on the test signal and the difference signal.

9. The device of claim 8 , wherein the processor determines at least one of an amplitude or a DC offset of the integrated signal, and indicates whether any of the first lead, the second lead, and the third lead are not adequately connected to the patient based on the at least one of the amplitude or the DC offset.

10. The device of claim 9 , wherein the processor determines whether at least one of the amplitude or the DC offset exceeds a respective threshold, and indicates that either the third lead, both the first lead and the second lead, or all leads are not adequately connected to the patient if the at least one of the amplitude or the DC offset exceeds the respective threshold.

11. The device of claim 8 , wherein the processor determines whether the difference signal exceeds a threshold, and indicates that either the first lead or the second lead is not adequately connected to the patient if the difference signal exceeds the threshold.

12. The device of claim 11 , wherein the processor determines a phase of the difference signal relative to the test signal, and indicates which of the first lead or the second lead is not adequately connected to the patient based on the phase.

13. The device of claim 8 , wherein the first lead is a left leg lead, the second lead is a right arm lead, and the third lead is a left arm lead.

14. The device of claim 8 , wherein the device comprises an automated external defibrillator.

15. A device, comprising

means for receiving a common mode signal via a first lead and a second lead coupled to an electrocardiogram monitoring device;

means for integrating a test signal and the common mode signal to generate an integrated signal; means for injecting the integrated signal into the third lead coupled to the electrocardiogram monitoring device;

means for generating a difference signal based on a difference between a first signal obtained via the first lead and a second signal obtained via the second lead; and

means for indicating which one or more of the first lead, the second lead, and the third lead are not adequately connected to a patient based on the integrated signal and the difference signal.

16. The device of claim 15 , further comprising means for determining at least one of an amplitude or a DC offset of the integrated signal, wherein the means for indicating comprises means for indicating whether any of the first lead, the second lead, and the third lead are not adequately connected to the patient based on the at least one of the amplitude or the DC offset.

17. The device of claim 16 , further comprising means for determining whether at least one of the amplitude or the DC offset exceeds a respective threshold, wherein the means for indicating comprises means for indicating that either the third lead, both the first lead and the second lead, or all leads are not adequately connected to the patient if the at least one of the amplitude or the DC offset exceeds the respective threshold.

18. The device of claim 15 , further comprising means for determining whether the difference signal exceeds a threshold, wherein the means for indicating comprises means for indicating that either the first lead or the second lead is not adequately connected to the patient if the difference signal exceeds the threshold.

19. The device of claim 18 , further comprising means for determining a phase of the difference signal relative to the test signal, wherein the means for indicating comprises means for indicating which of the first lead or the second lead is not adequately connected to the patient based on the phase.

Assignments (8)
RELEASE OF SECURITY INTEREST Recorded Apr 7, 2016
From: CITIBANK, N.A.
To: PHYSIO-CONTROL, INC.
Reel/Frame 038376/0806 →
RELEASE OF SECURITY INTEREST Recorded Apr 7, 2016
From: CITIBANK, N.A.
To: PHYSIO-CONTROL, INC.; PHYSIO-CONTROL INTERNATIONAL, INC.
Reel/Frame 038379/0001 →
RELEASE OF SECURITY INTEREST Recorded Apr 7, 2016
From: CITIBANK, N.A.
To: PHYSIO-CONTROL, INC.; PHYSIO-CONTROL INTERNATIONAL, INC.
Reel/Frame 038378/0028 →
SECOND LIEN SECURITY AGREEMENT Recorded Jan 19, 2016
From: PHYSIO-CONTROL, INC.; PHYSIO-CONTROL INTERNATIONAL, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 037559/0601 →
FIRST LIEN SECURITY AGREEMENT Recorded Jan 15, 2016
From: PHYSIO-CONTROL, INC.; PHYSIO-CONTROL INTERNATIONAL, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 037532/0828 →
RELEASE OF SECURITY INTEREST Recorded Jan 14, 2016
From: THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.
To: PHYSIO-CONTROL, INC.
Reel/Frame 037519/0240 →
SECURITY AGREEMENT Recorded Feb 10, 2012
From: PHYSIO-CONTROL, INC.
To: CITIBANK, N.A., AS COLLATERAL AGENT
Reel/Frame 027763/0881 →
SECURITY AGREEMENT Recorded Feb 9, 2012
From: PHYSIO-CONTROL, INC.
To: BANK OF NEW YORK MELLON TRUST COMPANY, N.A., AS *COLLATERAL TRUSTEE, THE
Reel/Frame 027765/0861 →